Skip to NavigationSkip to content

smart pills

‘Smart pill’ creator gains new funding

Proteus digital pill

Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients take their medications correctly and monitor vital signs.

This is the second round of funding that the US health and tech firm has managed to secure and comes after it raised $120 million from the first round of funding in June.

The money, from a number of international backers, will enable the company to advance the manufacturing and commercialisation of its digital medicines, it says in a statement.

Proteus to trial smart pills in UK

Smart pill image
Proteus' ingestible sensor invention

A US biotech specialising in smart pills is to set up its first manufacturing site in the UK creating 200 jobs, and is to begin a major trial of its products.

Proteus Digital Health will partner with NHS England and UK Trade & Investment (UKTI) to see whether its ingestible sensors - taken with drugs - more effectively monitor whether NHS patients follow their medicines regime.

Smart pills - or digital medicines - provide information about what medication has been taken, plus how well a patient’s body is responding via a plaster-like patch the patient wears.

Smart pills ‘set to boom’

Smart pill image

There will be an explosion in the development of smart pills used for internal imaging and even drug delivery within the next decade, according to new research by Frost & Sullivan.

Predicting a peak in new products between 2018 and 2020, the report says that technological advances in minimally invasive and remote-controlled devices are driving the market.

Some pills are already used for imaging and sensing but those for other applications - such as drug delivery and surgery - have yet to be proven clinically.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches